What does VERELST - DNA do?

VERELST - DNA is registered with the CBE as active in: Activiteiten van holdings. Private Limited, started on 15 May 2013, 1 establishment.

What is the address of VERELST - DNA?

The registered office of VERELST - DNA is located at Klein Boom 15, 2580 Putte.

Is VERELST - DNA still active?

Yes. According to the CBE (29 October 2026) VERELST - DNA is active, legal situation “Normale toestand”, started on 15 May 2013.

Is VERELST - DNA registered on Peppol?

Yes, VERELST - DNA is registered on the Peppol network with ID 0208:0534523646.

What is the enterprise number of VERELST - DNA?

The enterprise number of VERELST - DNA is BE0534523646.

When was VERELST - DNA founded?

VERELST - DNA was founded on 15 May 2013.

Who are the directors of VERELST - DNA?

According to the 2024 annual accounts, the directors of VERELST - DNA are: QUATOR CORONATI GEENS BV, VERBOCON BV, RC CONSTRUCT BV.

Is VERELST - DNA a reliable company?

Databakkes does not pass judgement; this is what the sources say: Active according to the CBE since 15 May 2013; 4 annual accounts filed, latest fiscal year 2024; 3 directors known from the annual account.

How much profit did VERELST - DNA make in 2024?

VERELST - DNA posted a profit after taxes of € 589,452 in financial year 2024.

What is the revenue of VERELST - DNA?

In its most recent annual accounts (2024), VERELST - DNA reported revenue of € 1,740,000.

VERELST - DNA (Private Limited) - Putte - BE0534523646

Dossier VERELST - DNA, printed on 29 October 2026 from databakkes.be/en/0534523646/verelst-dna. Sources: CBE, National Bank of Belgium, Belgian Official Gazette.

Warning lights

Signals from the annual accounts, the CBE and the Official Gazette, each with its threshold and source. No score, no verdict.

Tight liquidity NBB

Cash and receivables cover 30 % of short-term debt in 2024; threshold 65 %.
Busy address KBO

17 other companies have their registered office at the same address; threshold 10.

Financials

Financial year 2024

VERELST - DNA from Putte, company number BE0534523646, closed financial year 2024 with a result of € 589,452 after tax. For that financial year VERELST - DNA recorded revenue of € 1.7 million and equity of € 4 million. Compared with financial year 2023, the result moved from € 115,790 to € 589,452. Profitable, and profit is growing. The buffer is growing. Debts are under control. The most recent annual accounts were filed with the National Bank of Belgium on September 18, 2025.

What it is worth Growing

€ 4 million

▲ 17% vs 2023

Assets minus debts, by the books. What is left if everything were sold and paid today.

Profit Growing

€ 589,452

▲ € 473,662 vs 2023

Profit after tax over the fiscal year.

Cash in the bank

€ 9,903

▲ 95% vs 2023

Cash and bank balances on the last day of the fiscal year.

Where the profit goes Growing

Stays in the company

No dividend for 2024. Retained profit grew to € 3.2 million.

Debts at end 2024

Bank debt ≈ 71 years to go The accounts give the long-term loan and the part due within the year. The remainder divided by that part is the number of years at an equal pace; a new loan or early repayment changes it.

€ 12.5 million

▼ 23% vs 2023

€ 175,000 is repaid this year. At this pace the long-term loan is gone in ≈ 71 years.

Owed to suppliers

€ 36,994

▼ 49% vs 2023

Supplier invoices still open on the last day of the fiscal year. Pays suppliers within 18 days on average.

Taxes

€ 265,087

▲ € 259,009 vs 2023

Corporate tax and VAT still to pay. No wage debt: nothing outstanding to staff or social security.

Key figures per fiscal year Download key figures (CSV)
	2021	2022	2023	2024	Change 2023 → 2024
Revenue	€ 1,133,333 Revenue 2021: € 1,133,333 First fiscal year in the series	€ 1,300,000 Revenue 2022: € 1,300,000 ▲ 15% vs 2021 (€ 1,133,333) Favourable step	€ 1,340,000 Revenue 2023: € 1,340,000 ▲ 3% vs 2022 (€ 1,300,000) Favourable step	€ 1,740,000 Revenue 2024: € 1,740,000 ▲ 30% vs 2023 (€ 1,340,000) Favourable step	▲ 30%
Profit after taxes	€ -16,278 Profit after taxes 2021: € -16,278 First fiscal year in the series	€ 29,683 Profit after taxes 2022: € 29,683 ▲ € 45,961 vs 2021 (€ -16,278) Favourable step	€ 115,790 Profit after taxes 2023: € 115,790 ▲ 290% vs 2022 (€ 29,683) Favourable step	€ 589,452 Profit after taxes 2024: € 589,452 ▲ € 473,662 vs 2023 (€ 115,790) Favourable step	▲ € 473,662
Equity	€ 3,290,107 Equity 2021: € 3,290,107 First fiscal year in the series	€ 3,319,790 Equity 2022: € 3,319,790 ▲ 1% vs 2021 (€ 3,290,107) Favourable step	€ 3,435,580 Equity 2023: € 3,435,580 ▲ 3% vs 2022 (€ 3,319,790) Favourable step	€ 4,025,033 Equity 2024: € 4,025,033 ▲ 17% vs 2023 (€ 3,435,580) Favourable step	▲ 17%
Total debts	€ 13,059,992 Total debts 2021: € 13,059,992 First fiscal year in the series	€ 17,361,985 Total debts 2022: € 17,361,985 ▲ 33% vs 2021 (€ 13,059,992) Unfavourable step	€ 17,421,425 Total debts 2023: € 17,421,425 Unchanged (€ 17,361,985) Unfavourable step	€ 17,234,832 Total debts 2024: € 17,234,832 ▼ 1% vs 2023 (€ 17,421,425) Favourable step	▼ 1%
Cash	€ 137,989 Cash 2021: € 137,989 First fiscal year in the series	€ 135,776 Cash 2022: € 135,776 ▼ 2% vs 2021 (€ 137,989) Unfavourable step	€ 5,082 Cash 2023: € 5,082 ▼ 96% vs 2022 (€ 135,776) Unfavourable step	€ 9,903 Cash 2024: € 9,903 ▲ 95% vs 2023 (€ 5,082) Favourable step	▲ 95%
Retained profit	€ 2,507,089 Retained profit 2021: € 2,507,089 First fiscal year in the series	€ 2,536,772 Retained profit 2022: € 2,536,772 ▲ 1% vs 2021 (€ 2,507,089) Favourable step	€ 2,652,562 Retained profit 2023: € 2,652,562 ▲ 5% vs 2022 (€ 2,536,772) Favourable step	€ 3,242,015 Retained profit 2024: € 3,242,015 ▲ 22% vs 2023 (€ 2,652,562) Favourable step	▲ 22%
Bank debt	€ 11,937,595 Bank debt 2021: € 11,937,595 First fiscal year in the series	€ 16,389,419 Bank debt 2022: € 16,389,419 ▲ 37% vs 2021 (€ 11,937,595) Unfavourable step	€ 16,120,133 Bank debt 2023: € 16,120,133 ▼ 2% vs 2022 (€ 16,389,419) Favourable step	€ 12,461,813 Bank debt 2024: € 12,461,813 ▼ 23% vs 2023 (€ 16,120,133) Favourable step	▼ 23%
Balance sheet total	€ 16,350,099 Balance sheet total 2021: € 16,350,099 First fiscal year in the series	€ 20,681,775 Balance sheet total 2022: € 20,681,775 ▲ 26% vs 2021 (€ 16,350,099) Unchanged	€ 20,857,005 Balance sheet total 2023: € 20,857,005 ▲ 1% vs 2022 (€ 20,681,775) Unchanged	€ 21,259,865 Balance sheet total 2024: € 21,259,865 ▲ 2% vs 2023 (€ 20,857,005) Unchanged	▲ 2%

Key figures of VERELST - DNA, fiscal years 2021 to 2024, from the annual accounts filed with the National Bank of Belgium.The annual account for fiscal year 2025 has not been filed yet; it was expected before 31 July 2026.

What happened to VERELST - DNA?

What happened at VERELST - DNA in recent years, according to the Belgian Official Gazette, the CBE and the National Bank:

Sep 18, 2025 New annual accounts for financial year 2024: profit of € 589,452 (▲ € 473,662 vs 2023). filed late Source: NBB ↗
2023 QUATOR CORONATI GEENS BV became a director. NBB
2023 VERBOCON BV became a director. NBB
2023 RC CONSTRUCT BV became a director. NBB
May 16, 2013 New establishment in Putte. KBO
May 15, 2013 Start of the company according to the CBE. KBO

In short

From € 16,278 loss in 2021 to € 589,452 profit in 2024.

Paid € 155,935 in corporate taxes since 2021.

Best year ever: 2024, with € 589,452 profit.

Pays suppliers within 18 days on average.

Original PDFs at the National Bank ↗

Management

Verbocon 40%

The stake of Verbocon comes from that shareholder’s own annual accounts; small companies do not report their shareholders themselves.

VERELST - DNA

VERELST INTERNATIONAL 100%

BEDRIJFSBOUW EN PROJECTBOUW VERELST

BETONBOUW VERELST

WONINGBOUW VERELST

Behind VERELST - DNA are QUATOR CORONATI GEENS BV, VERBOCON BV and RC CONSTRUCT BV. The shares are held by Verbocon (40%). It owns 100% of VERELST INTERNATIONAL, BEDRIJFSBOUW EN PROJECTBOUW VERELST, BETONBOUW VERELST, WONINGBOUW VERELST, GROEP VERELST and TRANSPORT VERELST itself.